Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco A Zarbin

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
JAMA Ophthalmology|July 13, 2013
Combination therapy to reduce conjunctival scarring after glaucoma surgeryMarco A Zarbin
American Journal of Ophthalmology|March 28, 2007
Functionalizing cell-based therapy for age-related macular degenerationMarco A Zarbin
JAMA Ophthalmology|October 12, 2013
A New Target for Glaucoma TherapyMarco A Zarbin
Translational Vision Science & Technology|April 24, 2014
The Elusive Nature of Truth in Scientific Studies and the Importance of Peer ReviewMarco A Zarbin
Translational Vision Science & Technology|September 20, 2013
Welcome to <i>Translational Vision Science and Technology.</i>Marco A Zarbin
Translational Vision Science & Technology|September 20, 2013
Joanne Angle: 1941-2012Marco A Zarbin
Translational Vision Science & Technology|June 11, 2020
Artificial Intelligence: Quo Vadis?Marco A Zarbin
Retina (Philadelphia, Pa.)|April 23, 2026
Observations Regarding the 24-Month Results of the LIGHTSITE III TrialMarco A Zarbin
Ophthalmology|June 24, 2019
Extending Our Knowledge on Systemic Adverse Events Associated with Intravitreal Anti-Vascular Endothelial Growth Factor TherapyMarco A Zarbin
Transactions of the American Ophthalmological Society|February 20, 2004
Analysis of retinal pigment epithelium integrin expression and adhesion to aged submacular human Bruch's membraneMarco A Zarbin
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
JAMA Ophthalmology|July 13, 2013
Combination therapy to reduce conjunctival scarring after glaucoma surgeryMarco A Zarbin
American Journal of Ophthalmology|March 28, 2007
Functionalizing cell-based therapy for age-related macular degenerationMarco A Zarbin
JAMA Ophthalmology|October 12, 2013
A New Target for Glaucoma TherapyMarco A Zarbin
Translational Vision Science & Technology|April 24, 2014
The Elusive Nature of Truth in Scientific Studies and the Importance of Peer ReviewMarco A Zarbin
Translational Vision Science & Technology|September 20, 2013
Welcome to <i>Translational Vision Science and Technology.</i>Marco A Zarbin
Translational Vision Science & Technology|September 20, 2013
Joanne Angle: 1941-2012Marco A Zarbin
Translational Vision Science & Technology|June 11, 2020
Artificial Intelligence: Quo Vadis?Marco A Zarbin
Retina (Philadelphia, Pa.)|April 23, 2026
Observations Regarding the 24-Month Results of the LIGHTSITE III TrialMarco A Zarbin
Ophthalmology|June 24, 2019
Extending Our Knowledge on Systemic Adverse Events Associated with Intravitreal Anti-Vascular Endothelial Growth Factor TherapyMarco A Zarbin
Transactions of the American Ophthalmological Society|February 20, 2004
Analysis of retinal pigment epithelium integrin expression and adhesion to aged submacular human Bruch's membraneMarco A Zarbin
Pageof 16